Norden Group LLC Invests $250,000 in Vertex Pharmaceuticals

Norden Group LLC purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 615 shares of the pharmaceutical company’s stock, valued at approximately $250,000. A number of other […]

Related Keywords

Robertw Baird , Zurcher Kantonalbank Zurich Cantonalbank , Ourania Tatsis , Amit Sachdev , Sanfordc Bernstein , Vertex Pharmaceuticals Trading , Norden Group , Canaccord Genuity Group , Securities Exchange Commission , Vertex Pharmaceuticals Profile , Sherbrooke Park Advisers , Exchange Commission , Vertex Pharmaceuticals , Quarter For Vertex Pharmaceuticals , Morgan Stanley , News Ratings For Vertex Pharmaceuticals Daily , Telos Capital Management Inc , Vertex Pharmaceuticals Incorporated , Free Report , Park Advisers , Capital Management , Kantonalbank Zurich Cantonalbank , Pharmaceuticals Incorporated , Get Free Report , Genuity Group , Visit Holdingschannel , Vertex Pharmaceuticals Daily , Nasdaq Vrtx , Vrtx , Medical , 92532f10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,